{"id":"fructose","rwe":[],"_fda":{"id":"3e835d10-f329-3f7d-e063-6294a90ae8f0","set_id":"0cb9557b-d465-4c5a-80db-6f7d46afb05c","openfda":{"upc":["0093351000942"],"unii":["IY9XDZ35W2","6YSS42VSEV","E4GA8884NN"],"route":["ORAL"],"rxcui":["318146"],"spl_id":["3e835d10-f329-3f7d-e063-6294a90ae8f0"],"brand_name":["Discount Drug Mart nausea control Cherry Flavor"],"spl_set_id":["0cb9557b-d465-4c5a-80db-6f7d46afb05c"],"package_ndc":["53943-708-04"],"product_ndc":["53943-708"],"generic_name":["DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID"],"product_type":["HUMAN OTC DRUG"],"substance_name":["DEXTROSE, UNSPECIFIED FORM","FRUCTOSE","PHOSPHORIC ACID"],"manufacturer_name":["DISCOUNT DRUG MART"],"is_original_packager":[true]},"purpose":["Purpose Upset Stomach Reliever"],"version":"7","stop_use":["Stop use and ask a doctor if symptoms persist, return or get worse"],"warnings":["Warnings this product contains fructose and should not be taken by persons with hereditary fructose intolerance (HFI). Do not use if you have allergic reactions to any of the ingredients in this product Ask a doctor before use if you have diabetes Stop use and ask a doctor if symptoms persist, return or get worse If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)"],"ask_doctor":["Ask a doctor before use if you have diabetes"],"do_not_use":["Do not use if you have allergic reactions to any of the ingredients in this product"],"effective_time":"20250911","active_ingredient":["Active ingredients (per 5 mL) Dextrose (glucose) 1.87 g Levulose (fructose) 1.87 g Phosphoric acid 21.5 mg"],"inactive_ingredient":["Inactive ingredients FD&C red no. 40, flavors, glycerin, methylparaben, purified water."],"indications_and_usage":["Uses for relief of upset stomach associated with nausea"],"spl_unclassified_section":["Other information store at room temperature away from heat and direct light; keep from freezing do not use if printed seal under cap is broken or missing","NDC 53943-708-04 Compare to Emetrol ® active ingredients* Nausea Control upset stomach reliever safe for children with flu or fever. doctor recommended no salicylates no antihistamines no caffeine Cherry Flavor Naturally and Artificially Flavored 4fl oz (118 mL) Distributed By: Drug Mart-Food Fair 211 Commerce Dr., Medina, Ohio 44256 Questions?: 1-866-467-2748 *This product is not manufactured or distributed by Wellspring Pharmaceutical Corporation., owner of the registered trademark EMETROL ® ."],"dosage_and_administration":["Directions for maximum effectiveness never dilute or drink fluids of any kind immediately before or after taking this product repeat dose every 15 minutes or until distress subsides do not take more than 5 doses in 1 hour without consulting a doctor measure only with dosing cup provided. Dosing cup to be used with this product only. Do not use with other products. mL= milliliter age dose adults and children 12 years of age and over 15 mL or 30 mL children 2 to under 12 years of age 5 ml or 10 mL"],"spl_product_data_elements":["Discount Drug Mart nausea control Cherry Flavor dextrose(glucose),Levulose(fructose),Phosphoric acid FD&C RED NO. 40 GLYCERIN METHYLPARABEN WATER DEXTROSE, UNSPECIFIED FORM ANHYDROUS DEXTROSE FRUCTOSE FRUCTOSE PHOSPHORIC ACID PHOSPHORIC ACID Red"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use."],"keep_out_of_reach_of_children":["Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)"],"dosage_and_administration_table":["
agedose
adults and children 12 years of age and over15 mL or 30 mL
children 2 to under 12 years of age5 ml or 10 mL
"],"package_label_principal_display_panel":["PACKAGE LABEL Nausea Control Cherry Flavor"]},"tags":[{"label":"fructose","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Glycine receptor subunit alpha-1","category":"target"},{"label":"GLRA1","category":"gene"},{"label":"V06DC02","category":"atc"},{"label":"Oral","category":"route"},{"label":"Liquid","category":"form"},{"label":"Solution","category":"form"},{"label":"Active","category":"status"},{"label":"Flavoring Agents","category":"pharmacology"},{"label":"Food Additives","category":"pharmacology"},{"label":"Sweetening Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"5 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"DRY MOUTH","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"CONSTIPATION","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"COUGH","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"NEUROPATHY PERIPHERAL","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"2 reports"},{"date":"","signal":"WEIGHT DECREASED","source":"FDA FAERS","actionTaken":"2 reports"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=FRUCTOSE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:19:39.407201+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:19:45.302821+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FRUCTOSE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:19:45.605710+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:19:38.141294+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:19:38.141324+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:19:47.078474+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1089962/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:19:46.314364+00:00"}},"allNames":"levulose","offLabel":[],"synonyms":["D-Fructopyranose","fructose","D-(-)-Fructose","D-(-)-Levulose","D-arabino-2-Hexulose","fruit sugar","levulose","nevulose"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Levulose","ecosystem":[],"mechanism":{"target":"Glycine receptor subunit alpha-1","novelty":"First-in-class","targets":[{"gene":"GLRA1","source":"DrugCentral","target":"Glycine receptor subunit alpha-1","protein":"Glycine receptor subunit alpha-1"}],"modality":"Small Molecule","drugClass":"fructose","explanation":"","oneSentence":"","technicalDetail":"Levulose binds to the glycine receptor subunit alpha-1, modulating its activity and potentially influencing glycine-mediated neurotransmission and other physiological processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1252","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=FRUCTOSE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FRUCTOSE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:39:23.930916","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:19:48.446195+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"glucose","drugSlug":"glucose","fdaApproval":"1946-01-17","relationship":"same-class"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"fructose","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"glucose","brandName":"glucose","genericName":"glucose","approvalYear":"1946","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07494968","phase":"NA","title":"Defining Objective Markers of Compliance for Dietary Therapies in IBS","status":"NOT_YET_RECRUITING","sponsor":"University of Michigan","startDate":"2026-04","conditions":["Irritable Bowel Syndrome"],"enrollment":94,"completionDate":"2027-12"},{"nctId":"NCT05808023","phase":"NA","title":"Dose-dependent FODMAP Reintroduction in IBS","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2023-04-01","conditions":["Irritable Bowel Syndrome"],"enrollment":45,"completionDate":"2025-08-25"},{"nctId":"NCT04986631","phase":"EARLY_PHASE1","title":"Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-04-04","conditions":["Obesity, Childhood"],"enrollment":62,"completionDate":"2026-03-12"},{"nctId":"NCT07476989","phase":"NA","title":"Effects of Dual-Source Carbohydrate Intake and Liver Glycogen Repletion After Overnight Fasting.","status":"NOT_YET_RECRUITING","sponsor":"Manchester Metropolitan University","startDate":"2026-03","conditions":["Carbohydrate Metabolism","Hepatic Glycogen Storage","Healthy Adult Male"],"enrollment":12,"completionDate":"2026-12"},{"nctId":"NCT06972056","phase":"PHASE4","title":"Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":["Migraine"],"enrollment":1335,"completionDate":"2029-12-01"},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":["Obesity","Metabolic Syndrome X"],"enrollment":128,"completionDate":"2014-01-09"},{"nctId":"NCT05348395","phase":"NA","title":"Monocyte Priming When Consuming a Western Diet","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-01-06","conditions":["Heart Diseases"],"enrollment":8,"completionDate":"2024-10-11"},{"nctId":"NCT07209202","phase":"NA","title":"Fructose Intestinal Gluconeogenesis","status":"RECRUITING","sponsor":"Touro University, California","startDate":"2026-03-02","conditions":["Healthy Participants","Obese But Otherwise Healthy Participants"],"enrollment":40,"completionDate":"2030-06"},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":["Obesity"],"enrollment":120,"completionDate":"2027-07-31"},{"nctId":"NCT05371067","phase":"NA","title":"Fructose Effect on Neuroinflammation and Feelings","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2021-06-08","conditions":["Gastro-Intestinal Disorder"],"enrollment":56,"completionDate":"2022-05-16"},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":["Lactating Women on Select DOI","Breastfed Infants of Mothers on Select DOI"],"enrollment":1600,"completionDate":"2027-07-31"},{"nctId":"NCT02188680","phase":"NA","title":"Irritable Bowel Syndrome and Low FODMAP Diet","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2014-01","conditions":["Irritable Bowel Syndrome"],"enrollment":112,"completionDate":"2018-01"},{"nctId":"NCT06068894","phase":"NA","title":"Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-06-13","conditions":["Intestinal Health"],"enrollment":60,"completionDate":"2025-03-26"},{"nctId":"NCT07384624","phase":"PHASE1,PHASE2","title":"Combining Latency Reversing Agents to Address the HIV Reservoir","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2026-04","conditions":["HIV (Human Immunodeficiency Virus)","HIV -1 Infection"],"enrollment":30,"completionDate":"2028-07"},{"nctId":"NCT04621929","phase":"PHASE3","title":"Phentermine/Topiramate for Uric Acid Stones","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":["Obesity","Uric Acid Stones","Type 2 Diabetes Mellitus in Obese","Pre-Diabetes"],"enrollment":19,"completionDate":"2024-11-14"},{"nctId":"NCT04623502","phase":"NA","title":"An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-09-30","conditions":["Kidney Cancer","Renal Cell Carcinoma","Clear Cell Carcinoma","Urothelial Carcinoma","Metastatic Kidney Cancer","Metastatic Urothelial Carcinoma","Papillary Renal Cell Carcinoma","Chromophobe Renal Cell Carcinoma","Fumarate Hydratase Deficiency","Succinate Dehydrogenase-Deficient Renal Cell Carcinoma","HLRCC","Hereditary Leiomyomatosis and Renal Cell Cancer"],"enrollment":600,"completionDate":"2027-09-30"},{"nctId":"NCT07371949","phase":"NA","title":"CHRONO-NUTRITION APPLICATION: THE EFFECT OF FIBER JELLY ON POST PRANDIAL BLOOD GLUCOSE, SATIETY AND WEIGHT LOSS AMONG OVERWEIGHT WOMEN","status":"COMPLETED","sponsor":"Surabaya State University","startDate":"2025-06-30","conditions":["Overweight and Obese Adults"],"enrollment":28,"completionDate":"2025-12-14"},{"nctId":"NCT07360249","phase":"NA","title":"Glucose-fructose Ratio Pilot","status":"RECRUITING","sponsor":"University of Bath","startDate":"2026-01-14","conditions":["Exercise Metabolism"],"enrollment":10,"completionDate":"2026-08-01"},{"nctId":"NCT07337707","phase":"NA","title":"New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-02","conditions":["Irritable Bowel Syndrome (IBS)"],"enrollment":60,"completionDate":"2027-08"},{"nctId":"NCT07055269","phase":"NA","title":"Liver Metabolic Functions in Patients With Citrin Deficiency and Healthy Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johannes Haeberle","startDate":"2025-10-20","conditions":["Citrin Deficiency"],"enrollment":20,"completionDate":"2026-09"},{"nctId":"NCT07190989","phase":"NA","title":"A Replicate Crossover Trial on Nutritional Supplementation in Association Football (Soccer)","status":"COMPLETED","sponsor":"Aspire Academy","startDate":"2025-09-21","conditions":["Healthy"],"enrollment":15,"completionDate":"2025-11-01"},{"nctId":"NCT07058155","phase":"PHASE4","title":"Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-12-17","conditions":["Liver Cirrhoses","Portal Hypertension Related to Cirrhosis","Severe Obesity","TIPS"],"enrollment":70,"completionDate":"2034-02-01"},{"nctId":"NCT05795049","phase":"","title":"Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nottingham University Hospitals NHS Trust","startDate":"2024-07-23","conditions":["Irritable Bowel Syndrome (IBS)","Sucrase Isomaltase Deficiency"],"enrollment":2000,"completionDate":"2026-03-31"},{"nctId":"NCT06488534","phase":"NA","title":"Intracolonic FODMAP Infusion in Healthy Volunteers","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2023-06-26","conditions":["Irritable Bowel Syndrome"],"enrollment":15,"completionDate":"2024-12-13"},{"nctId":"NCT06329544","phase":"NA","title":"High Fructose Diet, the Gut Microbiome, and Metabolic Health","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-10-08","conditions":["MASLD","Type 2 Diabetes","Obesity"],"enrollment":30,"completionDate":"2028-08-31"},{"nctId":"NCT06426134","phase":"NA","title":"Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-12-01","conditions":["Schizophrenia and Related Disorders","Psychosis","Bipolar and Related Disorders","Manic Episode","Depressive Episode"],"enrollment":24,"completionDate":"2026-04-01"},{"nctId":"NCT02273804","phase":"PHASE3","title":"Topiramate and Severe Obesity","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-01","conditions":["Obese Children and Adolescents"],"enrollment":18,"completionDate":"2018-01-23"},{"nctId":"NCT06638190","phase":"NA","title":"Influence of the Fruit Matrix on Glucose and Insulin Responses After the Intake of Orange Juice in Healthy Human Males","status":"COMPLETED","sponsor":"María-Teresa García-Conesa","startDate":"2024-10-21","conditions":["Healthy Nutrition"],"enrollment":25,"completionDate":"2025-01-31"},{"nctId":"NCT03196466","phase":"","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-19","conditions":["Epilepsy"],"enrollment":753,"completionDate":"2023-06-15"},{"nctId":"NCT01182766","phase":"PHASE2,PHASE3","title":"New Treatment for Alcohol and Nicotine Dependence","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2011-11-01","conditions":["Alcohol Dependence","Nicotine Dependence"],"enrollment":236,"completionDate":"2017-10-06"},{"nctId":"NCT04881799","phase":"EARLY_PHASE1","title":"Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-07-07","conditions":["Pediatric Obesity"],"enrollment":13,"completionDate":"2026-10-27"},{"nctId":"NCT01514552","phase":"PHASE1","title":"The Use of Functional Confections in Promoting Oral Health","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2010-11","conditions":["Oral Health","Oral Cancer","Gum Disease"],"enrollment":36,"completionDate":"2026-04-10"},{"nctId":"NCT06799169","phase":"PHASE4","title":"Management of Acute Tinnitus With Migraine Medications","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2025-06-01","conditions":["Tinnitus"],"enrollment":100,"completionDate":"2026-12"},{"nctId":"NCT04190706","phase":"NA","title":"Synergistic Innovative Functional Food Concepts to Neutralize Inflammation for Cardiometabolic Risk Prevention","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2020-01-21","conditions":["Cardiometabolic Risk","Abdominal Obesity"],"enrollment":62,"completionDate":"2022-05-17"},{"nctId":"NCT07177781","phase":"NA","title":"Effects of Wild Blueberry Consumption on Brain Function in Elderly","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2024-12-05","conditions":["Brain Insulin-sensitivity","Brain Vascular Function","Cerebral Blood Flow"],"enrollment":36,"completionDate":"2026-08-31"},{"nctId":"NCT07175740","phase":"NA","title":"Effect of Macronutrients on Post-Exercise Glycemic Response in Males With Type 2 Diabetes","status":"COMPLETED","sponsor":"Paul Poirier","startDate":"2002-05-30","conditions":["Type 2 Diabetes","Glycemic Response"],"enrollment":15,"completionDate":"2004-05-28"},{"nctId":"NCT07175701","phase":"NA","title":"Ultra-processed Food Reducing Intervention and Continuous Glucose Monitoring","status":"NOT_YET_RECRUITING","sponsor":"Korea University","startDate":"2025-10-01","conditions":["Glycemic Variability","Postprandial Glucose","Glucose Levels","Glucose Level Change","Glycemic Control","Glucose","Hyperglycemias","Glucose Intolerance","Food Additives"],"enrollment":40,"completionDate":"2026-08-31"},{"nctId":"NCT06015490","phase":"NA","title":"The Impact of the Physiological Response to Sugar on Brain Activity and Behavior","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2023-09-01","conditions":["Food Preferences","Appetitive Behavior"],"enrollment":7,"completionDate":"2024-07-22"},{"nctId":"NCT05408728","phase":"","title":"Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2022-07-10","conditions":["Obese","Healthy","Bariatric Surgery Candidate"],"enrollment":52,"completionDate":"2026-08"},{"nctId":"NCT05756764","phase":"","title":"Anti-obesity Pharmacotherapy and Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2023-06-01","conditions":["Obesity"],"enrollment":30,"completionDate":"2026-02-20"},{"nctId":"NCT06648967","phase":"NA","title":"Impact of Different Carbohydrate Feedings on a Hydrogen Breath Curve and Self-reported Gastrointestinal Complaints","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arizona State University","startDate":"2024-10-03","conditions":["Quality of Life"],"enrollment":5,"completionDate":"2026-05-30"},{"nctId":"NCT07083232","phase":"PHASE4","title":"The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-30","conditions":["Diabetic","Myocardial Infarction"],"enrollment":50,"completionDate":"2024-11-30"},{"nctId":"NCT07105826","phase":"NA","title":"Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men","status":"RECRUITING","sponsor":"Texas Christian University","startDate":"2025-08-04","conditions":["Olipop","Poppi","Coca Cola - Classic","Diet Coke"],"enrollment":10,"completionDate":"2025-12-10"},{"nctId":"NCT05756621","phase":"","title":"Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2022-01-15","conditions":["Status Epilepticus","Cardiac Arrest"],"enrollment":80,"completionDate":"2025-09-30"},{"nctId":"NCT04308473","phase":"NA","title":"Analysis of MicroBial Metabolites After Eating Refined Food","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-09-01","conditions":["Dietary Habits"],"enrollment":46,"completionDate":"2026-07"},{"nctId":"NCT03241706","phase":"PHASE1","title":"Liver Glycogen and Hypoglycemia in Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jason Winnick","startDate":"2018-08-02","conditions":["Hypoglycemia; Iatrogenic"],"enrollment":40,"completionDate":"2028-05-31"},{"nctId":"NCT06671756","phase":"NA","title":"Metabolic Effects of Fructose Intake","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2024-12-02","conditions":["Healthy"],"enrollment":8,"completionDate":"2025-05-31"},{"nctId":"NCT07013916","phase":"NA","title":"Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2025-06-30","conditions":["MASH - Metabolic Dysfunction-Associated Steatohepatitis","MASH With Fibrosis","Steatosis of Liver"],"enrollment":72,"completionDate":"2026-04-01"},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":["Adolescent Obesity"],"enrollment":150,"completionDate":"2025-03-11"},{"nctId":"NCT07058116","phase":"PHASE1","title":"Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.","status":"RECRUITING","sponsor":"Neutron Therapeutics, LLC","startDate":"2025-05-08","conditions":["Head and Neck Carcinoma"],"enrollment":10,"completionDate":"2026-01-30"},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":["Epilepsies, Partial"],"enrollment":58,"completionDate":"2024-06-30"},{"nctId":"NCT04572217","phase":"PHASE2","title":"Medications After Adolescent Bariatric Surgery","status":"WITHDRAWN","sponsor":"Janey Pratt","startDate":"2022-06-01","conditions":["Pediatric Obesity"],"enrollment":0,"completionDate":"2022-06-01"},{"nctId":"NCT05748483","phase":"PHASE3","title":"Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2023-10-07","conditions":["Migraine"],"enrollment":545,"completionDate":"2026-05"},{"nctId":"NCT04095104","phase":"PHASE2","title":"Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-15","conditions":["Obesity, Morbid","Bariatric Surgery","Adolescent","Young Adult","Drug Therapy"],"enrollment":13,"completionDate":"2022-01-25"},{"nctId":"NCT05761301","phase":"PHASE1,PHASE2","title":"A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM","status":"TERMINATED","sponsor":"Alnylam Pharmaceuticals","startDate":"2023-03-10","conditions":["Type 2 Diabetes Mellitus (T2DM)"],"enrollment":49,"completionDate":"2025-04-03"},{"nctId":"NCT02201251","phase":"PHASE3","title":"A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-10-06","conditions":["Epilepsy"],"enrollment":63,"completionDate":"2020-04-30"},{"nctId":"NCT06941740","phase":"NA","title":"Effects of Reactive Hypoglycaemia on Cognition in Earlier or Later Chronotypes","status":"ENROLLING_BY_INVITATION","sponsor":"Anette Buyken","startDate":"2025-04-04","conditions":["Healthy"],"enrollment":177,"completionDate":"2027-07-31"},{"nctId":"NCT06852612","phase":"NA","title":"Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-04-24","conditions":["Glycogen Storage Disease Type I"],"enrollment":20,"completionDate":"2027-03"},{"nctId":"NCT06427915","phase":"NA","title":"Studying Glucose and Appetite Response With Alternatives to Soda Pop","status":"COMPLETED","sponsor":"Olipop, PBC","startDate":"2024-05-15","conditions":["Healthy Nutrition"],"enrollment":30,"completionDate":"2024-06-21"},{"nctId":"NCT04613024","phase":"EARLY_PHASE1","title":"Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2025-07-01","conditions":["Weight Loss","Pain, Postoperative"],"enrollment":0,"completionDate":"2027-07-01"},{"nctId":"NCT02283814","phase":"PHASE1","title":"A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-01","conditions":["Epilepsy"],"enrollment":32,"completionDate":"2007-02"},{"nctId":"NCT04168372","phase":"NA","title":"Fructose: Substrate, Stimulus, or Both?","status":"COMPLETED","sponsor":"Touro University, California","startDate":"2019-09-15","conditions":["Insulin Resistance","Insulin Sensitivity","Pre Diabetes"],"enrollment":35,"completionDate":"2024-11-20"},{"nctId":"NCT00394095","phase":"PHASE4","title":"Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-12","conditions":["Bipolar Disorder","Weight Gain"],"enrollment":31,"completionDate":"2009-09"},{"nctId":"NCT03667846","phase":"PHASE2","title":"Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2019-10-10","conditions":["Post Traumatic Stress Disorder","Alcohol Use Disorder"],"enrollment":150,"completionDate":"2025-08-31"},{"nctId":"NCT06895018","phase":"NA","title":"Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"Federico II University","startDate":"2024-05-03","conditions":["Diabetes Mellitus Type 2"],"enrollment":20,"completionDate":"2025-10-31"},{"nctId":"NCT03596788","phase":"NA","title":"Effects of Different Sports Supplements on Metabolism and Perceptual Responses During Distance Running","status":"TERMINATED","sponsor":"Old Dominion University","startDate":"2018-08-01","conditions":["Anomalies Gastrointestinal"],"enrollment":4,"completionDate":"2025-02-17"},{"nctId":"NCT04382079","phase":"NA","title":"Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Taipei Medical University","startDate":"2020-04-08","conditions":["Oral Mucositis"],"enrollment":75,"completionDate":"2022-04-15"},{"nctId":"NCT05315206","phase":"NA","title":"Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione G.B. Bietti, IRCCS","startDate":"2022-01-25","conditions":["Primary Open Angle Glaucoma"],"enrollment":29,"completionDate":"2025-07"},{"nctId":"NCT05826717","phase":"NA","title":"Effect of Matrices on Serum Fructose.","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2022-12-15","conditions":["Fructose Metabolism Disorder"],"enrollment":23,"completionDate":"2024-12-20"},{"nctId":"NCT06832423","phase":"NA","title":"CAN CREATINE SUPPLEMENTATION IMPROVE PERFORMANCE in ROCK CLIMBERS?","status":"WITHDRAWN","sponsor":"Bangor University","startDate":"2016-01","conditions":["Rock Climbing"],"enrollment":0,"completionDate":"2017-03-01"},{"nctId":"NCT06799715","phase":"NA","title":"Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-02-06","conditions":["Gastrointestinal Hormones","Glycemic Control","Blood Coagulation Function","Gastric Emptying"],"enrollment":20,"completionDate":"2026-06"},{"nctId":"NCT05444699","phase":"PHASE4","title":"Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age","status":"RECRUITING","sponsor":"University of Oulu","startDate":"2022-10-11","conditions":["Bronchiolitis Acute Viral"],"enrollment":210,"completionDate":"2027-09"},{"nctId":"NCT04966299","phase":"NA","title":"Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-18","conditions":["Insulin Resistance","Glucose Tolerance","Body Composition","Gastrointestinal Tolerance","Thrombocyte Aggregation","Blood p-Selectin","Blood Erythritol","Blood Xylitol"],"enrollment":30,"completionDate":"2025-04"},{"nctId":"NCT06795854","phase":"NA","title":"Effect of Aerobic Training Versus Relaxation Techniques on Quality of Life in Patients With Post Covid-19 Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-02-01","conditions":["Irritable Bowel Syndrome"],"enrollment":60,"completionDate":"2025-05-15"},{"nctId":"NCT03188835","phase":"NA","title":"Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2017-05-23","conditions":["Type2 Diabetes"],"enrollment":15,"completionDate":"2021-04-30"},{"nctId":"NCT06322407","phase":"NA","title":"Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-06-01","conditions":["Chronic Migraine"],"enrollment":206,"completionDate":"2025-12-01"},{"nctId":"NCT06471582","phase":"NA","title":"Timing of Energy Availability on Menstrual Cycle Function","status":"RECRUITING","sponsor":"University of Colorado, Colorado Springs","startDate":"2024-08-01","conditions":["Menstrual Irregularity"],"enrollment":64,"completionDate":"2027-08-31"},{"nctId":"NCT06770907","phase":"","title":"Genetic Carbohydrate Maldigestion As Model to Study Food Hypersensitivity Mechanism (WORK PACKAGE 2)","status":"NOT_YET_RECRUITING","sponsor":"University of Nottingham","startDate":"2025-03","conditions":["Sucrase Isomaltase Deficiency"],"enrollment":80,"completionDate":"2026-03"},{"nctId":"NCT06751862","phase":"NA","title":"The Role of Sugars in Fat Accumulation in the Liver","status":"RECRUITING","sponsor":"Institute for Clinical and Experimental Medicine","startDate":"2024-06-20","conditions":["Fatty Liver Disease"],"enrollment":40,"completionDate":"2027-03"},{"nctId":"NCT04994418","phase":"NA","title":"The Impact of Sodium and Fructose on Blood Pressure and Inflammation","status":"COMPLETED","sponsor":"University of Delaware","startDate":"2021-04-01","conditions":["Blood Pressure","Inflammation"],"enrollment":91,"completionDate":"2024-04-15"},{"nctId":"NCT06715800","phase":"NA","title":"Honey Against Sore Throat","status":"COMPLETED","sponsor":"Medipol University","startDate":"2022-01-06","conditions":["Sore Throat","Honey"],"enrollment":282,"completionDate":"2022-09-12"},{"nctId":"NCT06541938","phase":"NA","title":"AIRE-2 Device for Study of Breath Analysis in IBD","status":"RECRUITING","sponsor":"McMaster University","startDate":"2024-08-28","conditions":["Inflammatory Bowel Diseases"],"enrollment":60,"completionDate":"2027-12-31"},{"nctId":"NCT01689649","phase":"PHASE4","title":"A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2008-05-02","conditions":["Epilepsy"],"enrollment":139,"completionDate":"2010-01-19"},{"nctId":"NCT05136092","phase":"NA","title":"A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-02-16","conditions":["Colorectal Tumors"],"enrollment":12,"completionDate":"2024-09-27"},{"nctId":"NCT03783195","phase":"NA","title":"Genetic-specific Effects of Fructose on Liver Lipogenesis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-01-25","conditions":["NAFLD"],"enrollment":15,"completionDate":"2023-04-25"},{"nctId":"NCT01950520","phase":"PHASE2","title":"Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-02-07","conditions":["Healthy Volunteers"],"enrollment":47,"completionDate":"2024-06-11"},{"nctId":"NCT05528471","phase":"NA","title":"Fructose and Liver Diseases in Youth: Help Them FLY","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2015-04-30","conditions":["Non-alcoholic Fatty Liver Disease"],"enrollment":70,"completionDate":"2024-12-30"},{"nctId":"NCT06440343","phase":"NA","title":"Effects of Acute Carbohydrate Intake Intra-training in Crosstraining","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2024-05-01","conditions":["Recovery"],"enrollment":25,"completionDate":"2024-09-01"},{"nctId":"NCT04924530","phase":"NA","title":"Effect of Lactose on Blood Lipids","status":"COMPLETED","sponsor":"University of Bath","startDate":"2021-06-07","conditions":["Cardiovascular Risk Factor","Lipaemia","Metabolic Disease"],"enrollment":26,"completionDate":"2023-07-21"},{"nctId":"NCT00904943","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":["Healthy"],"enrollment":18,"completionDate":"2002-07"},{"nctId":"NCT00905164","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":["Healthy"],"enrollment":24,"completionDate":"2002-06"},{"nctId":"NCT05017675","phase":"NA","title":"Effect of Dietary SFA and Fructose on Hepatic Insulin Sensitivity","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2021-11-08","conditions":["Insulin Resistance"],"enrollment":20,"completionDate":"2024-05-24"},{"nctId":"NCT00905346","phase":"PHASE1","title":"Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":["Healthy"],"enrollment":24,"completionDate":"2002-07"},{"nctId":"NCT00905606","phase":"PHASE1","title":"Topiramate 25 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2001-06","conditions":["Healthy"],"enrollment":30,"completionDate":"2001-06"},{"nctId":"NCT05582837","phase":"PHASE4","title":"Treatment of Meniere's Disease With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2022-08-01","conditions":["Ménière"],"enrollment":100,"completionDate":"2026-12-30"},{"nctId":"NCT06539494","phase":"PHASE2","title":"Luminal Fructose Kinetics (MARTINI Study)","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-07-01","conditions":["MASLD"],"enrollment":22,"completionDate":"2026-04"},{"nctId":"NCT04092439","phase":"NA","title":"The Effects of Watermelon Juice Supplementation on Postprandial Vascular Endothelial Function","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2019-09-12","conditions":["Endothelial Dysfunction"],"enrollment":18,"completionDate":"2020-03-20"},{"nctId":"NCT03500484","phase":"EARLY_PHASE1","title":"Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.","status":"TERMINATED","sponsor":"Yale University","startDate":"2018-06-06","conditions":["Obesity, Childhood","Neural Development"],"enrollment":13,"completionDate":"2020-06-25"},{"nctId":"NCT06256653","phase":"NA","title":"Assess the Effect of a Whole Fruit Powder on Gut Microbiome Function on Overweight & Obese Adults","status":"RECRUITING","sponsor":"University College Cork","startDate":"2024-01-29","conditions":["Obesity","Overweight and Obesity"],"enrollment":120,"completionDate":"2025-10"},{"nctId":"NCT06248931","phase":"PHASE3","title":"Valproate Versus Topiramate in Migraine","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":["Migraine Disorders"],"enrollment":600,"completionDate":"2024-06-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Liquid, Solution","formulations":[{"form":"LIQUID","route":"ORAL","productName":"Anti Nausea"},{"form":"LIQUID","route":"ORAL","productName":"Best Choice Anti NauseaCherry Flavor"},{"form":"LIQUID","route":"ORAL","productName":"CVS Anti NauseaCherry Flavor"},{"form":"LIQUID","route":"ORAL","productName":"Good Neighbor Anti NauseaCherry Flavor"},{"form":"LIQUID","route":"ORAL","productName":"HEB Anti Nausea"},{"form":"LIQUID","route":"ORAL","productName":"Kroger Anti NauseaCherry Flavor"},{"form":"LIQUID","route":"ORAL","productName":"Meijer Anti Nausea"},{"form":"SOLUTION","route":"ORAL","productName":"Anti Nausea Liquid"},{"form":"SOLUTION","route":"ORAL","productName":"Anti Nausea LiquidCherry Flavor"},{"form":"SOLUTION","route":"ORAL","productName":"Discount Drug Mart nausea controlCherry Flavor"},{"form":"SOLUTION","route":"ORAL","productName":"Emetrol Cherry"},{"form":"SOLUTION","route":"ORAL","productName":"Good Neighbor Pharmacy Nausea Relief"},{"form":"SOLUTION","route":"ORAL","productName":"Health Mart anti nausea"},{"form":"SOLUTION","route":"ORAL","productName":"Nausea Relief"},{"form":"SOLUTION","route":"ORAL","productName":"Premier Value Nausea ControlCherry Flavor"}]},"crossReferences":{"NUI":"N0000147002","MMSL":"NOCODE","NDDF":"000918","UNII":"6YSS42VSEV","VUID":"4018693","CHEBI":"CHEBI:28757","VANDF":"4018693","RXNORM":"4570","UMLSCUI":"C0016745","chemblId":"CHEMBL1089962","ChEMBL_ID":"CHEMBL604608","KEGG_DRUG":"D00114","DRUGBANK_ID":"DB04173","PDB_CHEM_ID":" BDF","PUBCHEM_CID":"2723872","SNOMEDCT_US":"39860005","SECONDARY_CAS_RN":"57-48-7","MESH_DESCRIPTOR_UI":"D005632"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"50%"},"publicationCount":40788,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"V06DC02","allCodes":["V06DC02"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":6,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:19:48.446195+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}